Back to medical news
Medical Xpress
GLP-1 drugs linked to lower kidney failure risk in bipolar disorder
October 19, 2026
Original source summary
Mayo Clinic researchers found that GLP-1 receptor agonists, medications widely used for diabetes and weight management, were associated with a lower risk of dialysis or kidney transplantation in adults with bipolar disorder and chronic kidney disease.
Verbatim from Medical Xpress's own feed — "GLP-1 drugs linked to lower kidney failure risk in bipolar disorder"
Want more like this?
Browse more from the feed. A free account unlocks the full feed, saving and communities.
More medical news